These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 7506658
1. Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats. Bisaga A, Krzascik P, Jankowska E, Palejko W, Kostowski W, Danysz W. Eur J Pharmacol; 1993 Oct 05; 242(3):213-20. PubMed ID: 7506658 [Abstract] [Full Text] [Related]
3. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity. Arnt J, Sánchez C, Lenz SM, Madsen U, Krogsgaard-Larsen P. Eur J Pharmacol; 1995 Oct 24; 285(3):289-97. PubMed ID: 8575516 [Abstract] [Full Text] [Related]
4. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity. Bigge CF, Malone TC, Boxer PA, Nelson CB, Ortwine DF, Schelkun RM, Retz DM, Lescosky LJ, Borosky SA, Vartanian MG. J Med Chem; 1995 Sep 15; 38(19):3720-40. PubMed ID: 7562904 [Abstract] [Full Text] [Related]
9. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Bespalov A, Dravolina O, Belozertseva I, Adamcio B, Zvartau E. Behav Pharmacol; 2006 Jun 28; 17(4):295-302. PubMed ID: 16914947 [Abstract] [Full Text] [Related]
10. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Chapman AG, Graham JL, Patel S, Meldrum BS. Epilepsia; 1991 Jun 28; 32(4):578-87. PubMed ID: 1678345 [Abstract] [Full Text] [Related]
13. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons. Liljequist S, Cebers G, Kalda A. Biochem Pharmacol; 1995 Nov 27; 50(11):1761-74. PubMed ID: 8615854 [Abstract] [Full Text] [Related]
15. Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo. Obrenovitch TP, Urenjak J, Zilkha E. Br J Pharmacol; 1994 Dec 27; 113(4):1295-302. PubMed ID: 7534184 [Abstract] [Full Text] [Related]
16. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Gill R. Cerebrovasc Brain Metab Rev; 1994 Dec 27; 6(3):225-56. PubMed ID: 7529037 [Abstract] [Full Text] [Related]